HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiji Asaoka Selected Research

NK 252

7/2013Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiji Asaoka Research Topics

Disease

1Atrophy
07/2021
1Hyperplasia
07/2021
1Hypertrophy
04/2016
1Fibrosis (Cirrhosis)
07/2013
1Crohn Disease (Crohn's Disease)
10/2011
1Autoimmune Diseases (Autoimmune Disease)
10/2011
1Adenocarcinoma
02/2004
1Neoplasms (Cancer)
02/2004

Drug/Important Bio-Agent (IBA)

1GlycogenIBA
07/2021
1ClofibrateFDA Link
04/2016
1Hematoxylin (Haematoxylon)IBA
04/2016
1Eosine Yellowish-(YS) (Eosin)IBA
04/2016
1EnzymesIBA
04/2016
1Phenobarbital (Luminal)FDA Link
04/2016
1LipidsIBA
04/2016
1CDAA (Randox)IBA
07/2013
1NK 252IBA
07/2013
1Alanine Transaminase (SGPT)IBA
10/2011
1doramapimodIBA
10/2011
1Biomarkers (Surrogate Marker)IBA
10/2011
1p38 Mitogen-Activated Protein KinasesIBA
10/2011
1MucinsIBA
02/2004
1Galactose OxidaseIBA
02/2004